17.80
price down icon0.17%   -0.03
after-market After Hours: 17.50 -0.30 -1.69%
loading
Structure Therapeutics Inc Adr stock is traded at $17.80, with a volume of 943.72K. It is down -0.17% in the last 24 hours and down -14.18% over the past month. Structure Therapeutics Inc is a clinical-stage biopharmaceutical company developing novel oral small-molecule therapeutics to treat a wide range of chronic diseases with unmet medical needs. Its differentiated technology platform leverages both structure-based drug discovery and expertise in computational chemistry to discover and develop small molecule therapeutics against G-protein coupled receptors (GPCRs). The group operates and manages its business as one reportable and operating segment, which is the business of research and development of medicines that target chronic diseases with unmet medical needs.
See More
Previous Close:
$17.83
Open:
$18.19
24h Volume:
943.72K
Relative Volume:
1.21
Market Cap:
$1.02B
Revenue:
-
Net Income/Loss:
$-100.44M
P/E Ratio:
-8.018
EPS:
-2.22
Net Cash Flow:
$-105.32M
1W Performance:
-2.57%
1M Performance:
-14.18%
6M Performance:
-40.61%
1Y Performance:
-52.39%
1-Day Range:
Value
$17.55
$18.34
1-Week Range:
Value
$17.45
$18.78
52-Week Range:
Value
$13.22
$45.37

Structure Therapeutics Inc Adr Stock (GPCR) Company Profile

Name
Name
Structure Therapeutics Inc Adr
Name
Phone
(628) 229-9277
Name
Address
611 GATEWAY BLVD SUITE 223, SOUTH SAN FRANCISCO
Name
Employee
183
Name
Twitter
Name
Next Earnings Date
Name
Latest SEC Filings
Name
GPCR's Discussions on Twitter

Compare GPCR with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Biotechnology icon
GPCR
Structure Therapeutics Inc Adr
17.80 1.03B 0 -100.44M -105.32M -2.22
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
456.87 120.48B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
545.46 59.88B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
392.24 44.31B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
670.33 36.65B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
301.13 32.46B 3.81B -644.79M -669.77M -6.24

Structure Therapeutics Inc Adr Stock (GPCR) Upgrades & Downgrades

Date Action Analyst Rating Change
May-02-25 Initiated Citigroup Buy
Feb-28-25 Initiated William Blair Outperform
Jan-08-25 Initiated Stifel Buy
Dec-04-24 Initiated H.C. Wainwright Buy
Sep-23-24 Initiated Morgan Stanley Overweight
May-21-24 Initiated JP Morgan Overweight
Apr-09-24 Initiated Cantor Fitzgerald Overweight
Oct-19-23 Initiated JMP Securities Mkt Outperform
Jul-27-23 Initiated Piper Sandler Overweight
May-25-23 Resumed Jefferies Buy
Feb-28-23 Initiated BMO Capital Markets Outperform
Feb-28-23 Initiated Guggenheim Buy
Feb-28-23 Initiated Jefferies Buy
Feb-28-23 Initiated SVB Securities Outperform
View All

Structure Therapeutics Inc Adr Stock (GPCR) Latest News

pulisher
Jul 31, 2025

Chefs’ Warehouse (NASDAQ:CHEF) Reaches New 52-Week High After Better-Than-Expected Earnings - Defense World

Jul 31, 2025
pulisher
Jul 31, 2025

Brokerages Set Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM) Price Target at $65.50 - Defense World

Jul 31, 2025
pulisher
Jul 31, 2025

Brookfield (NYSE:BN) Upgraded at National Bank Financial - Defense World

Jul 31, 2025
pulisher
Jul 30, 2025

Camden National (NASDAQ:CAC) Stock Price Down 7.6% Following Weak Earnings - Defense World

Jul 30, 2025
pulisher
Jul 30, 2025

Century Lithium (OTC:CYDVF) Shares Down 2.6% – What’s Next? - Defense World

Jul 30, 2025
pulisher
Jul 30, 2025

Eupraxia Pharmaceuticals (OTCMKTS:EPRXF) Shares Down 0.9% – Here’s What Happened - Defense World

Jul 30, 2025
pulisher
Jul 30, 2025

HCM Acquisition (NASDAQ:HCMA) Stock Price Down 3.4% – Here’s Why - Defense World

Jul 30, 2025
pulisher
Jul 30, 2025

DeFi Technologies (OTC:DEFTF) Trading 20% Higher – What’s Next? - Defense World

Jul 30, 2025
pulisher
Jul 30, 2025

GCM Grosvenor (NASDAQ:GCMGW) Trading Up 1.1% – Should You Buy? - Defense World

Jul 30, 2025
pulisher
Jul 30, 2025

Encore Capital Group (NASDAQ:ECPG) & Manhattan Bridge Capital (NASDAQ:LOAN) Critical Review - Defense World

Jul 30, 2025
pulisher
Jul 28, 2025

Obesity Clinical Trials, Companies, Therapeutic Assessment, - openPR.com

Jul 28, 2025
pulisher
Jul 25, 2025

Analysts Are Bullish on These Healthcare Stocks: Thermo Fisher (TMO), Viking Therapeutics (VKTX) - The Globe and Mail

Jul 25, 2025
pulisher
Jul 24, 2025

Private Advisor Group LLC Buys 489 Shares of Quanta Services, Inc. (NYSE:PWR) - Defense World

Jul 24, 2025
pulisher
Jul 24, 2025

Analysts Are Bullish on Top Healthcare Stocks: HOYA (HOCPF), Align Tech (ALGN) - The Globe and Mail

Jul 24, 2025
pulisher
Jul 24, 2025

Microchip Technology Incorporated (NASDAQ:MCHP) Holdings Decreased by Private Advisor Group LLC - Defense World

Jul 24, 2025
pulisher
Jul 24, 2025

Amazon.com, Inc. (NASDAQ:AMZN) Shares Sold by Shilanski & Associates Inc. - Defense World

Jul 24, 2025
pulisher
Jul 22, 2025

Arcosa, Inc. (NYSE:ACA) Shares Sold by Cerity Partners LLC - Defense World

Jul 22, 2025
pulisher
Jul 18, 2025

Analysts Offer Insights on Healthcare Companies: Ligand Pharma (LGND) and Sarepta Therapeutics (SRPT) - The Globe and Mail

Jul 18, 2025
pulisher
Jul 17, 2025

Ajax Therapeutics and Schrödinger Expand Research Collaboration to Include Additional JAK Target - Business Wire

Jul 17, 2025
pulisher
Jul 16, 2025

Analysts Offer Insights on Healthcare Companies: Iovance Biotherapeutics (IOVA) and Eli Lilly & Co (LLY) - The Globe and Mail

Jul 16, 2025
pulisher
Jul 16, 2025

Analysts Offer Insights on Healthcare Companies: AbbVie (ABBV) and Alkermes (ALKS) - The Globe and Mail

Jul 16, 2025
pulisher
Jul 15, 2025

H.C. Wainwright Sticks to Its Buy Rating for Structure Therapeutics, Inc. Sponsored ADR (GPCR) - The Globe and Mail

Jul 15, 2025
pulisher
Jul 13, 2025

Principal Financial Group Inc. Has $14.24 Million Stock Holdings in Universal Display Corporation (NASDAQ:OLED) - Defense World

Jul 13, 2025
pulisher
Jul 13, 2025

Principal Financial Group Inc. Decreases Stock Holdings in Shift4 Payments, Inc. (NYSE:FOUR) - Defense World

Jul 13, 2025
pulisher
Jul 13, 2025

Principal Financial Group Inc. Sells 11,305 Shares of Nova Ltd. (NASDAQ:NVMI) - Defense World

Jul 13, 2025
pulisher
Jul 13, 2025

Principal Financial Group Inc. Lowers Holdings in Structure Therapeutics Inc. Sponsored ADR (NASDAQ:GPCR) - Defense World

Jul 13, 2025
pulisher
Jul 06, 2025

Analysts Offer Insights on Healthcare Companies: Corbus Pharmaceuticals (CRBP), Amedisys (AMED) and Xoma (XOMA) - The Globe and Mail

Jul 06, 2025
pulisher
Jul 03, 2025

Structure in partnering talks for GLP-1 pill as mid-stage readout nears - Endpoints News

Jul 03, 2025
pulisher
Jul 02, 2025

Scage Future shares rise 2.16% in after-hours after extending business merger agreement deadline and establishing ADR facility. - AInvest

Jul 02, 2025
pulisher
Jun 25, 2025

Structure Therapeutics Holds 2025 Annual Shareholders Meeting - TipRanks

Jun 25, 2025
pulisher
Jun 24, 2025

Structure Therapeutics (NASDAQ:GPCR) Receives “Market Outperform” Rating from JMP Securities - Defense World

Jun 24, 2025
pulisher
Jun 23, 2025

TriSalus Life Sciences Announces Commencement of Exchange Offer and Consent Solicitation Relating to Series A Convertible Preferred Stock to Streamline Capital Structure - Business Wire

Jun 23, 2025
pulisher
Jun 20, 2025

Breakthrough Oral Obesity Drug Matches Injectable Results, Shows Added Benefits With Wegovy in Trial Data - Stock Titan

Jun 20, 2025
pulisher
Jun 18, 2025

Analysts Offer Insights on Healthcare Companies: Pfizer (PFE) and Sagimet Biosciences, Inc. Class A (SGMT) - The Globe and Mail

Jun 18, 2025
pulisher
Jun 14, 2025

Data-Based Insights About Structure Therapeutics Inc ADR (GPCR) - Stocksregister

Jun 14, 2025
pulisher
Jun 12, 2025

Oral Proteins & Peptides Market worth US$24.00 billion by 2030 with 22.1% CAGR | MarketsandMarkets™METRO - METRO - NEWS CHANNEL NEBRASKA

Jun 12, 2025
pulisher
Jun 12, 2025

Cantor Fitzgerald Comments on GPCR FY2026 Earnings - Defense World

Jun 12, 2025
pulisher
Jun 12, 2025

Oral Proteins & Peptides Market worth US$24.00 billion by 2030 with 22.1% CAGR | MarketsandMarketsNORTHEAST - NORTHEAST - NEWS CHANNEL NEBRASKA

Jun 12, 2025
pulisher
Jun 11, 2025

Cantor Fitzgerald Estimates GPCR FY2025 Earnings - Defense World

Jun 11, 2025
pulisher
Jun 09, 2025

Oral Proteins and Peptides Market Report Latest Trends and Future Opportunities Analysis - openPR.com

Jun 09, 2025
pulisher
Jun 08, 2025

Structure Therapeutics Inc. (NASDAQ:GPCR) Given Average Recommendation of “Buy” by Brokerages - Defense World

Jun 08, 2025
pulisher
Jun 06, 2025

Structure Therapeutics, Inc.: Catalyst-Rich Outlook and Strategic Preparations Support Buy Rating - TipRanks

Jun 06, 2025
pulisher
Jun 05, 2025

Bank of America Corp DE Has $1.47 Million Position in Structure Therapeutics Inc. (NASDAQ:GPCR) - Defense World

Jun 05, 2025
pulisher
Jun 05, 2025

Viking Therapeutics at Jefferies Conference: Promising Weight Loss Drug - Investing.com

Jun 05, 2025
pulisher
Jun 03, 2025

GLP-1 Receptor Agonists: The Surge of M&A Activity and the Future of Metabolic Health - The National Law Review

Jun 03, 2025
pulisher
May 29, 2025

Structure Therapeutics Set for Jefferies and Goldman Sachs Healthcare Conference Presentations in June - Stock Titan

May 29, 2025
pulisher
May 29, 2025

Telomir Pharmaceuticals Confirms Telomir-1 Restores Vision and Retinal Structure in Age-Related Macular Degeneration (AMD) Animal Model Using FDA-Recognized Surrogate Endpoints - standard-journal.com

May 29, 2025
pulisher
May 28, 2025

BNP Paribas Financial Markets Increases Stake in scPharmaceuticals Inc. (NASDAQ:SCPH) - Defense World

May 28, 2025
pulisher
May 28, 2025

BNP Paribas Financial Markets Makes New $304,000 Investment in Structure Therapeutics Inc. (NASDAQ:GPCR) - Defense World

May 28, 2025
pulisher
May 28, 2025

Bucking Biotech's Downward Trend, Circle Pharma Heads To Larger Space - Bisnow

May 28, 2025
pulisher
May 26, 2025

Analysts Have Conflicting Sentiments on These Healthcare Companies: Novo Nordisk (NVO), Beam Therapeutics (BEAM) and TScan Therapeutics (TCRX) - The Globe and Mail

May 26, 2025

Structure Therapeutics Inc Adr Stock (GPCR) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$74.89
price down icon 3.43%
$36.80
price down icon 0.86%
$107.28
price up icon 2.00%
$26.37
price down icon 1.09%
$107.50
price down icon 2.32%
biotechnology ONC
$301.13
price up icon 0.40%
Cap:     |  Volume (24h):